Zevra Therapeutics
(NASDAQ:ZVRA)
$4.52
0[0.00%]
At close: Apr 26
$4.52
0[0.00%]
After Hours: 4:20PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Zevra Therapeutics Stock (NASDAQ:ZVRA), Quotes and News Summary

Zevra Therapeutics Stock (NASDAQ: ZVRA) stock price, news, charts, stock research, profile.

Open$4.520
Close$4.520
Volume / Avg.157.431K / 249.363K
Day Range4.480 - 4.600
52 Wk Range3.890 - 7.280
Market Cap$189.164M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
30
Short Interest
5.4%
Days to Cover10.32

Recent News

Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Why Is Acer Therapeutics Stock Trading Higher Today?
Zevra Therapeutics Inc (NASDAQ: ZVRA) has agreed to acquire Acer Therapeutics Inc (NASDAQ: ACER) for up to $91 million.
Vandana Singh
Sponsored
Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock?
The late-stage biopharma Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is approaching the conclusion of the phase 3 trial for its drug, Mino-Lok.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Dec 23
2
Mar
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Zevra Therapeutics Inc
Sector
Health Care
Industry
Pharmaceuticals
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to creat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ZVRA
AVIR

FAQ

Q

How do I buy Zevra Therapeutics (ZVRA) stock?

A

You can purchase shares of Zevra Therapeutics (NASDAQ: ZVRA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Zevra Therapeutics's (ZVRA) competitors?

A

Other companies in Zevra Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN), Rani Therapeutics Hldgs (NASDAQ:RANI) and Alimera Sciences (NASDAQ:ALIM).

Q

What is the target price for Zevra Therapeutics (ZVRA) stock?

A

The latest price target for Zevra Therapeutics (NASDAQ: ZVRA) was reported by HC Wainwright & Co. on Wednesday, April 3, 2024. The analyst firm set a price target for 15.00 expecting ZVRA to rise to within 12 months (a possible 231.86% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Zevra Therapeutics (ZVRA)?

A

The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $4.52 last updated April 26, 2024 at 4:20 PM EDT.

Q

Does Zevra Therapeutics (ZVRA) pay a dividend?

A

There are no upcoming dividends for Zevra Therapeutics.

Q

When is Zevra Therapeutics (NASDAQ:ZVRA) reporting earnings?

A

Zevra Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Q

Is Zevra Therapeutics (ZVRA) going to split?

A

There is no upcoming split for Zevra Therapeutics.

Q

What sector and industry does Zevra Therapeutics (ZVRA) operate in?

A

Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch